CORC

浏览/检索结果: 共4条,第1-4条 帮助

已选(0)清除 条数/页:   排序方式:
Discovery of 2,4-diarylaminopyrimidines bearing a resorcinol motif as novel ALK inhibitors to overcome the G1202R resistant mutation 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 144, 页码: 386-397
作者:  Geng, Kaijun;  Xia, Zongjun;  Ji, Yinchun;  Zhang, Ruisi (Ruthy);  Sun, Deqiao
收藏  |  浏览/下载:155/0  |  提交时间:2019/01/08
Discovery of Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent Inhibitory Activities against Both Wild-type and Mutant ALK Kinases 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 卷号: 58, 期号: 1, 页码: 197-211
作者:  Song, Zilan;  Yang, Yanhong;  Liu, Zhiqing;  Peng, Xia;  Guo, Junfeng
收藏  |  浏览/下载:17/0  |  提交时间:2019/01/08
Design, synthesis and pharmacological evaluation of 2-(thiazol-2-amino)-4-arylaminopyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 卷号: 86, 页码: 438-448
作者:  Liu, Zhiqing;  Yue, Xihua;  Song, Zilan;  Peng, Xia;  Guo, Junfeng
收藏  |  浏览/下载:58/0  |  提交时间:2019/01/08
Novel 2,4-Diarylanninopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities 期刊论文
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 卷号: 5, 期号: 4, 页码: 304-308
作者:  Liu, Zhiqing;  Ai, Jing;  Peng, Xia;  Song, Zilan;  Wu, Kui
收藏  |  浏览/下载:55/0  |  提交时间:2019/01/08


©版权所有 ©2017 CSpace - Powered by CSpace